Suzanne Swan
Nephrology · Minneapolis, MNNPI 1740223171
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,013 of the $1,623 with a category attached, or 62.4%. Every reported general payment came from a single manufacturer, Boehringer Ingelheim International GmbH.
Across 13 payments — averaging $124.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$2K
Across 251 payments — averaging $8228.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$1.2M
- Merck$732K
- Kowa Research Institute, Inc.$46K
- Boehringer Ingelheim International GmbH$41K
- Janssen Research & Development, LLC$25K
- Novavax Inc$18K
- plus $10K from 2 others
What the payments were for
- Travel & lodging$1,01362%
- Food & beverage$61038%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 13 | $1,623 |
How this compares
$1,623 in reported general payments places this provider in the 80th percentile of 208 nephrology providers in Minnesota.
Other nephrology in Minneapolis
- Kirsten JohansenMinneapolis$101K
- Jeffrey KohenMinneapolis$56K
- James WetmoreMinneapolis$48K
- Robert FoleyMinneapolis$12K
- Jeffrey ConnaireMinneapolis$11K
- Patrick NachmanMinneapolis$7K
- Charles SmithMinneapolis$4K
- Mirna BoumitriMinneapolis$3K
- Jiwan ThapaMinneapolis$3K
- Arda AkolukMinneapolis$777
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.